The Mitochondrial Candidate: Effects of BAM15 on BRAFV600E Melanoma

被引:0
|
作者
Rangel, C. [1 ]
Li, K. [1 ]
Chipuk, J. [1 ]
Serasinghe, M. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
D135
引用
收藏
页码:S264 / S265
页数:2
相关论文
共 50 条
  • [1] cAMP signaling in BRAFV600E melanoma
    Rodriguez, Carlos I.
    CANCER RESEARCH, 2014, 74 (19)
  • [2] MITOCHONDRIAL METABOLIC REPROGRAMMING OF MELANOMA CELLS EXPOSED TO BRAFV600E INHIBITOR
    Kluza, J.
    Jendoubi, M.
    Corazao-Rozas, P.
    Andre, F.
    Jonneaux, A.
    Guerreschi, P.
    Formstecher, P.
    Mortier, L.
    Marchetti, P. H. I.
    ANNALS OF ONCOLOGY, 2013, 24 : 30 - 30
  • [3] Modulation of MHC expression by BRAFV600E in melanoma
    Pollack, B. P.
    Sapkota, B.
    Hill, C. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S224 - S224
  • [4] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    J S Wilmott
    A M Menzies
    L E Haydu
    D Capper
    M Preusser
    Y E Zhang
    J F Thompson
    R F Kefford
    A von Deimling
    R A Scolyer
    G V Long
    British Journal of Cancer, 2013, 108 : 924 - 931
  • [5] Intrapatient Homogeneity of BRAFV600E Expression in Melanoma
    Menzies, Alexander M.
    Lum, Trina
    Wilmott, James S.
    Hyman, Jessica
    Kefford, Richard F.
    Thompson, John F.
    O'Toole, Sandra
    Long, Georgina V.
    Scolyer, Richard A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (03) : 377 - 382
  • [6] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    Wilmott, J. S.
    Menzies, A. M.
    Haydu, L. E.
    Capper, D.
    Preusser, M.
    Zhang, Y. E.
    Thompson, J. F.
    Kefford, R. F.
    von Deimling, A.
    Scolyer, R. A.
    Long, G. V.
    BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 924 - 931
  • [7] Melanoma Drug Approved for Patients With BRAFV600E
    Smart, Michael
    ONCOLOGY NURSING FORUM, 2011, 38 (06) : 739 - 740
  • [8] Mutant specific mitochondrial localization of BRAFV600E: Clinically used BRAF kinase inhibitors are not able to block mitochondrial actions of BRAFV600E
    Lee, Min Hee
    Kim, Koon Soon
    Lee, Seong Eun
    Ryu, Min Jeong
    Kim, Soung Joong
    Kim, Yong Kyoung
    Kweon, Gi Ryang
    Jo, Young Suk
    Shong, Minho
    CANCER RESEARCH, 2010, 70
  • [9] Mitochondrial Localization and Regulation of BRAFV600E in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAFV600E
    Lee, Min Hee
    Lee, Seong Eun
    Kim, Dong Wook
    Ryu, Min Jeong
    Kim, Sung Jin
    Kim, Sung Joong
    Kim, Yong Kyoung
    Park, Ji Hoon
    Kweon, Gi Ryang
    Kim, Jin Man
    Lee, Jung Uee
    De Falco, Valentina
    Jo, Young Suk
    Shong, Minho
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (01): : E19 - E30
  • [10] Expression of AID in malignant melanoma with BRAFV600E mutation
    Nakamura, M.
    Okura, R.
    Yoshioka, H.
    Yoshioka, M.
    Hiromasa, K.
    Nishio, D.
    FEBS JOURNAL, 2014, 281 : 465 - 465